Veeva Shares Slip Despite Beating Q1 Estimates: Details
Summary
Veeva reported stronger-than-expected first-quarter earnings and revenue, but the stock still fell in after-hours trading. Subscription revenue rose 15% year over year, showing continued demand for its software platform. Management also said Veeva AI is progressing quickly and described the company’s shift toward an industry-specific application and AI agent model. The company raised its fiscal 2027 guidance for both adjusted EPS and revenue.
Classifications
industries
HealthTech
applications
Web and Content Management
AskAI Classifications
Labels
Life Sciences Software
Clinical Trial Software
Regulatory Software
Linked Companies
Veeva Systems
$1M to $5M